1. Home
  2. EMBC vs CHY Comparison

EMBC vs CHY Comparison

Compare EMBC & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • CHY
  • Stock Information
  • Founded
  • EMBC 1924
  • CHY 2003
  • Country
  • EMBC United States
  • CHY United States
  • Employees
  • EMBC N/A
  • CHY N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • CHY Investment Managers
  • Sector
  • EMBC Health Care
  • CHY Finance
  • Exchange
  • EMBC Nasdaq
  • CHY Nasdaq
  • Market Cap
  • EMBC 788.4M
  • CHY 839.8M
  • IPO Year
  • EMBC N/A
  • CHY N/A
  • Fundamental
  • Price
  • EMBC $15.11
  • CHY $11.19
  • Analyst Decision
  • EMBC Buy
  • CHY
  • Analyst Count
  • EMBC 2
  • CHY 0
  • Target Price
  • EMBC $18.50
  • CHY N/A
  • AVG Volume (30 Days)
  • EMBC 507.0K
  • CHY 128.3K
  • Earning Date
  • EMBC 08-08-2025
  • CHY 01-01-0001
  • Dividend Yield
  • EMBC 3.90%
  • CHY 10.11%
  • EPS Growth
  • EMBC 18.26
  • CHY N/A
  • EPS
  • EMBC 1.42
  • CHY N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • CHY N/A
  • Revenue This Year
  • EMBC N/A
  • CHY N/A
  • Revenue Next Year
  • EMBC N/A
  • CHY N/A
  • P/E Ratio
  • EMBC $10.82
  • CHY N/A
  • Revenue Growth
  • EMBC N/A
  • CHY N/A
  • 52 Week Low
  • EMBC $9.20
  • CHY $9.97
  • 52 Week High
  • EMBC $21.48
  • CHY $12.16
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 66.06
  • CHY 65.13
  • Support Level
  • EMBC $14.51
  • CHY $10.80
  • Resistance Level
  • EMBC $15.44
  • CHY $11.25
  • Average True Range (ATR)
  • EMBC 0.50
  • CHY 0.09
  • MACD
  • EMBC -0.04
  • CHY 0.03
  • Stochastic Oscillator
  • EMBC 79.59
  • CHY 84.44

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CHY Calamos Convertible and High Income Fund

Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.

Share on Social Networks: